JP2019524797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019524797A5 JP2019524797A5 JP2019506699A JP2019506699A JP2019524797A5 JP 2019524797 A5 JP2019524797 A5 JP 2019524797A5 JP 2019506699 A JP2019506699 A JP 2019506699A JP 2019506699 A JP2019506699 A JP 2019506699A JP 2019524797 A5 JP2019524797 A5 JP 2019524797A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- alkyl
- ring
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 18
- -1 guanidino, amidino Chemical group 0.000 claims description 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 40
- 239000000203 mixture Substances 0.000 claims 20
- 125000000217 alkyl group Chemical group 0.000 claims 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 12
- 229910052760 oxygen Inorganic materials 0.000 claims 12
- 239000001301 oxygen Substances 0.000 claims 12
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000011593 sulfur Substances 0.000 claims 10
- 229910052717 sulfur Inorganic materials 0.000 claims 10
- 208000003251 Pruritus Diseases 0.000 claims 8
- 125000003342 alkenyl group Chemical group 0.000 claims 8
- 125000000304 alkynyl group Chemical group 0.000 claims 8
- 125000004122 cyclic group Chemical group 0.000 claims 8
- 125000005842 heteroatom Chemical group 0.000 claims 8
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- CVQUWLDCFXOXEN-UHFFFAOYSA-N Pyran-4-one Chemical compound O=C1C=COC=C1 CVQUWLDCFXOXEN-UHFFFAOYSA-N 0.000 claims 6
- 239000006071 cream Substances 0.000 claims 6
- 239000002552 dosage form Substances 0.000 claims 6
- 238000009472 formulation Methods 0.000 claims 6
- 125000001041 indolyl group Chemical group 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical group O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 claims 4
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 4
- 125000004423 acyloxy group Chemical group 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- XKCJYMCNPFBMQW-UHFFFAOYSA-N cyano(nitramido)cyanamide Chemical compound [O-][N+](=O)NN(C#N)C#N XKCJYMCNPFBMQW-UHFFFAOYSA-N 0.000 claims 4
- 239000006260 foam Substances 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 4
- 239000003921 oil Substances 0.000 claims 4
- 235000019198 oils Nutrition 0.000 claims 4
- 239000002674 ointment Substances 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000007921 spray Substances 0.000 claims 4
- 125000005504 styryl group Chemical group 0.000 claims 4
- 150000003573 thiols Chemical class 0.000 claims 4
- 230000000699 topical effect Effects 0.000 claims 4
- 239000002671 adjuvant Substances 0.000 claims 3
- 229940035676 analgesics Drugs 0.000 claims 3
- 239000000730 antalgic agent Substances 0.000 claims 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims 3
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 3
- 239000003963 antioxidant agent Substances 0.000 claims 3
- 230000003078 antioxidant effect Effects 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 239000003085 diluting agent Substances 0.000 claims 3
- 239000003995 emulsifying agent Substances 0.000 claims 3
- 239000000839 emulsion Substances 0.000 claims 3
- 239000000499 gel Substances 0.000 claims 3
- 239000003755 preservative agent Substances 0.000 claims 3
- 230000002335 preservative effect Effects 0.000 claims 3
- 230000002685 pulmonary effect Effects 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- 239000002904 solvent Substances 0.000 claims 3
- 238000013268 sustained release Methods 0.000 claims 3
- 239000012730 sustained-release form Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 239000003204 tranquilizing agent Substances 0.000 claims 3
- 230000002936 tranquilizing effect Effects 0.000 claims 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 108091006146 Channels Proteins 0.000 claims 2
- 229920002261 Corn starch Polymers 0.000 claims 2
- 101000654386 Homo sapiens Sodium channel protein type 9 subunit alpha Proteins 0.000 claims 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 2
- 102000003563 TRPV Human genes 0.000 claims 2
- 108060008564 TRPV Proteins 0.000 claims 2
- 125000002252 acyl group Chemical group 0.000 claims 2
- 150000003973 alkyl amines Chemical class 0.000 claims 2
- 150000001356 alkyl thiols Chemical class 0.000 claims 2
- 125000005018 aryl alkenyl group Chemical group 0.000 claims 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 125000005015 aryl alkynyl group Chemical group 0.000 claims 2
- 125000001821 azanediyl group Chemical group [H]N(*)* 0.000 claims 2
- 150000001540 azides Chemical class 0.000 claims 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 239000008120 corn starch Substances 0.000 claims 2
- 239000007884 disintegrant Substances 0.000 claims 2
- 239000000796 flavoring agent Substances 0.000 claims 2
- 235000013355 food flavoring agent Nutrition 0.000 claims 2
- 235000003599 food sweetener Nutrition 0.000 claims 2
- 239000003349 gelling agent Substances 0.000 claims 2
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 2
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 2
- 239000008101 lactose Substances 0.000 claims 2
- 239000000314 lubricant Substances 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 2
- SOWBFZRMHSNYGE-UHFFFAOYSA-N oxamic acid Chemical compound NC(=O)C(O)=O SOWBFZRMHSNYGE-UHFFFAOYSA-N 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 2
- 239000003765 sweetening agent Substances 0.000 claims 2
- 239000005526 vasoconstrictor agent Substances 0.000 claims 2
- 229940124549 vasodilator Drugs 0.000 claims 2
- 239000003071 vasodilator agent Substances 0.000 claims 2
- 244000215068 Acacia senegal Species 0.000 claims 1
- 241000416162 Astragalus gummifer Species 0.000 claims 1
- 241000167854 Bourreria succulenta Species 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 229920000084 Gum arabic Polymers 0.000 claims 1
- 244000246386 Mentha pulegium Species 0.000 claims 1
- 235000016257 Mentha pulegium Nutrition 0.000 claims 1
- 235000004357 Mentha x piperita Nutrition 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- 229920000881 Modified starch Polymers 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229920001615 Tragacanth Polymers 0.000 claims 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims 1
- 241001135917 Vitellaria paradoxa Species 0.000 claims 1
- 235000010489 acacia gum Nutrition 0.000 claims 1
- 239000000205 acacia gum Substances 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- 150000004781 alginic acids Chemical class 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 235000019693 cherries Nutrition 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 239000003240 coconut oil Substances 0.000 claims 1
- 235000019864 coconut oil Nutrition 0.000 claims 1
- 230000036576 dermal application Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000010685 fatty oil Substances 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 235000001050 hortel pimenta Nutrition 0.000 claims 1
- 230000007803 itching Effects 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 239000006186 oral dosage form Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims 1
- 229940081974 saccharin Drugs 0.000 claims 1
- 235000019204 saccharin Nutrition 0.000 claims 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims 1
- 229940057910 shea butter Drugs 0.000 claims 1
- 239000007909 solid dosage form Substances 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 125000000185 sucrose group Chemical group 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 229940100611 topical cream Drugs 0.000 claims 1
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 1
- 239000009637 wintergreen oil Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662378435P | 2016-08-23 | 2016-08-23 | |
| US62/378,435 | 2016-08-23 | ||
| PCT/IB2017/053989 WO2018037295A1 (en) | 2016-08-23 | 2017-06-30 | Method for treating pruritus and/or itch |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019524797A JP2019524797A (ja) | 2019-09-05 |
| JP2019524797A5 true JP2019524797A5 (enExample) | 2020-06-18 |
| JP6910424B2 JP6910424B2 (ja) | 2021-07-28 |
Family
ID=59416750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019506699A Active JP6910424B2 (ja) | 2016-08-23 | 2017-06-30 | 掻痒症および／または痒みの治療方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20190175554A1 (enExample) |
| EP (1) | EP3503884B1 (enExample) |
| JP (1) | JP6910424B2 (enExample) |
| KR (1) | KR20190040298A (enExample) |
| CN (1) | CN109843286A (enExample) |
| AU (1) | AU2017315265C1 (enExample) |
| CA (1) | CA3033534A1 (enExample) |
| MX (1) | MX381311B (enExample) |
| SG (1) | SG11201901449XA (enExample) |
| TW (1) | TW201808269A (enExample) |
| WO (1) | WO2018037295A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7048051B2 (ja) * | 2018-07-11 | 2022-04-05 | 正徳 染井 | 痒みを軽減するアトピー性皮膚炎治療剤 |
| WO2021151059A1 (en) * | 2020-01-24 | 2021-07-29 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compounds and methods for treating or reducing pruritus |
| CN119118953A (zh) * | 2020-03-11 | 2024-12-13 | 诺西恩医疗公司 | 带电的离子通道阻滞剂及其使用方法 |
| AU2022380979A1 (en) | 2021-11-02 | 2024-06-06 | Flare Therapeutics Inc. | Pparg inverse agonists and uses thereof |
| WO2024229352A2 (en) * | 2023-05-04 | 2024-11-07 | Caamtech, Inc. | Tryptamine derivatives |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5521183A (en) * | 1994-08-30 | 1996-05-28 | Allergan | Use of 5-HT ligands as anti-pruritic agents |
| CA2224660A1 (en) * | 1995-06-14 | 1997-01-03 | Institute Of Immunology Co., Ltd. | A pharmaceutical agent for the treatment of pruritus cutaneus associated with renal failure |
| DE69715049T2 (de) * | 1996-02-07 | 2003-04-03 | Kissei Pharmaceutical Co., Ltd. | Tranilast enthaltendes externum und verfahren zu dessen herstellung |
| WO1997035565A1 (en) * | 1996-03-27 | 1997-10-02 | Toray Industries, Inc. | Ketone derivatives and medicinal use thereof |
| JP2000327570A (ja) * | 1999-05-24 | 2000-11-28 | Nof Corp | 皮膚外用剤 |
| US6552073B1 (en) * | 2002-03-01 | 2003-04-22 | Exonhit Therapeutics Sa | Compounds and methods of treating cell proliferative diseases |
| US9101613B2 (en) * | 2006-02-15 | 2015-08-11 | Neurim Pharmaceuticals (1991) Ltd. | Methods for treating neurological disease |
| US7635710B2 (en) * | 2006-02-15 | 2009-12-22 | Neurim Pharmaceuticals (1991) Ltd. | Pyrone-indole derivatives and process for their preparation |
| JP5513705B2 (ja) * | 2006-03-29 | 2014-06-04 | 小林製薬株式会社 | 知覚過敏型肌掻痒感改善剤 |
| US20080131496A1 (en) * | 2006-09-22 | 2008-06-05 | Guilford F Timothy | Topical application of melatonin directly or in liposomes for the amelioration of itching and histamine and non histamine related inflammatory skin changes |
| KR101359078B1 (ko) * | 2011-03-08 | 2014-02-05 | 이홍식 | 자주색 산삼배양근의 제조방법 |
| WO2014144545A2 (en) * | 2013-03-15 | 2014-09-18 | Genentech, Inc. | Substituted benzoxazoles and methods of use thereof |
| CN105492430B (zh) * | 2013-03-15 | 2017-10-10 | 基因泰克公司 | 取代的苯并噁唑及其使用方法 |
-
2017
- 2017-06-30 SG SG11201901449XA patent/SG11201901449XA/en unknown
- 2017-06-30 MX MX2019002149A patent/MX381311B/es unknown
- 2017-06-30 KR KR1020197008201A patent/KR20190040298A/ko not_active Ceased
- 2017-06-30 AU AU2017315265A patent/AU2017315265C1/en active Active
- 2017-06-30 US US16/324,707 patent/US20190175554A1/en not_active Abandoned
- 2017-06-30 CA CA3033534A patent/CA3033534A1/en not_active Abandoned
- 2017-06-30 WO PCT/IB2017/053989 patent/WO2018037295A1/en not_active Ceased
- 2017-06-30 JP JP2019506699A patent/JP6910424B2/ja active Active
- 2017-06-30 EP EP17745509.4A patent/EP3503884B1/en active Active
- 2017-06-30 CN CN201780052128.4A patent/CN109843286A/zh active Pending
- 2017-08-02 TW TW106125990A patent/TW201808269A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019524797A5 (enExample) | ||
| JP2005519083A5 (enExample) | ||
| NZ587547A (en) | Modulators of ATP-Binding Cassette Transporters | |
| KR920702359A (ko) | 치료용 헤테로사이클 화합물 | |
| JP2010514758A5 (enExample) | ||
| JP2004519469A5 (enExample) | ||
| AU2020263285B2 (en) | Continuous delivery of lenalidomide and other immunomodulatory agents | |
| JP2003509349A5 (enExample) | ||
| JP2004526720A5 (enExample) | ||
| CA2656716C (fr) | Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique | |
| CA2401502A1 (en) | Carboxylic acid derivatives as ip antagonists | |
| WO2007050726A3 (en) | Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists | |
| JP2008521827A5 (enExample) | ||
| JP2002520316A5 (enExample) | ||
| UA85359C2 (ru) | Таблетка, содержащая гранулированный материал с kmd-3213 | |
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| JPWO2021041348A5 (enExample) | ||
| RU2007116987A (ru) | Новые соединения | |
| JP2004533986A5 (enExample) | ||
| JP2019182865A5 (enExample) | ||
| BG65472B1 (bg) | Използване на саредутант и неговите фармацевтичноприемливи соли за приготвяне на лекарствено средство за използване за лечение или профилактика на голямо депресивно разтройство | |
| CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
| JP2019516726A5 (enExample) | ||
| CA2299400C (en) | Method for treating disease-related or drug-induced dyskinesias | |
| CA2523253A1 (en) | Methyl indoles and methyl pyrrolopyridines as alpha-1 adrenergic agonists |